View up-to-date information on Arcus Biosciences Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2021240068A1 | Application | Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha | A61K31/10; A61K31/277; A61K31/343; A61K31/353; A61K31/365; A61K31/381; A61K31/404; A61K31/415; A61K31/416; A61K31/4174; A61K31/4192; A61K31/4196; A61K31/421; A61K31/423; A61K31/426; A61K31/428; A61K31/437; A61K31/44; A61K31/4412; A61K31/47; A61K31/4709; A61K31/472; A61K31/4965; A61K31/50; A61K31/5025; A61K31/505; A61K31/519; A61K31/538; A61K39/3955; A61K45/06; A61P35/00; C07C255/52; C07C255/53; C07C255/57; C07C255/59; C07C2602/08; C07C2602/10; C07C317/22; C07C317/32; C07C317/36; C07D209/34; C07D211/86; C07D213/26; C07D213/30; C07D213/57; C07D213/61; C07D213/64; C07D213/71; C07D213/73; C07D213/74; C07D213/84; C07D215/18; C07D215/36; C07D215/48; C07D217/02; C07D217/04; C07D231/12; C07D231/14; C07D231/56; C07D233/64; C07D237/20; C07D239/28; C07D239/42; C07D241/12; C07D241/20; C07D249/06; C07D249/08; C07D263/32; C07D263/56; C07D263/57; C07D265/36; C07D277/24; C07D277/30; C07D277/40; C07D277/56; C07D277/62; C07D277/64; C07D307/83; C07D307/88; C07D311/22; C07D311/58; C07D333/64; C07D401/04; C07D401/10; C07D409/04; C07D409/10; C07D413/04; C07D413/10; C07D471/04; C07D487/04 | September 08, 2022 |
| US11407712B2 | Grant | Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2a | A61K31/10; A61K31/277; A61K31/343; A61K31/353; A61K31/365; A61K31/381; A61K31/404; A61K31/415; A61K31/416; A61K31/4174; A61K31/4192; A61K31/4196; A61K31/421; A61K31/423; A61K31/426; A61K31/428; A61K31/437; A61K31/44; A61K31/4412; A61K31/47; A61K31/4709; A61K31/472; A61K31/4965; A61K31/50; A61K31/5025; A61K31/505; A61K31/519; A61K31/538; A61K39/3955; A61K45/06; C07C255/53; C07C2602/08; C07C2602/10; C07C317/22; C07C317/32; C07C317/36; C07D209/34; C07D211/86; C07D213/57; C07D213/71; C07D213/73; C07D213/74; C07D213/84; C07D215/48; C07D217/04; C07D231/12; C07D231/56; C07D233/64; C07D237/20; C07D239/42; C07D241/12; C07D249/06; C07D249/08; C07D263/32; C07D263/57; C07D265/36; C07D277/30; C07D277/56; C07D277/64; C07D307/83; C07D311/22; C07D333/64; C07D401/04; C07D401/10; C07D409/10; C07D413/10; C07D471/04; C07D487/04 | August 09, 2022 |
| US20220241313A1 | Application | TREATMENT OF ONCOGENE-DRIVEN CANCERS | A61K31/282; A61K31/506; A61K31/704; A61K31/7064; A61K31/7076; A61K33/243; A61K39/3955; A61P35/00 | August 04, 2022 |
| EP3893891A4 | Search Report | FESTE FORMEN EINES CD73-INHIBITORS UND DEREN VERWENDUNG | A61K31/282; A61K31/555; A61K31/704; A61K31/706; A61K33/243; A61K45/06; A61P35/00; C07H19/23 | August 03, 2022 |
| US20220235031A1 | Application | PROCESSES FOR PREPARING AMINOPYRIMIDINE COMPOUNDS | C07D239/42; C07D401/14 | July 28, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer